Gene-drug interactions (data source: DGIdb)
Gene Name Entrez ID Drug Name Chembl ID Interaction Types Sources publications
MET 4233 ALTIRATINIB CHEMBL3545365 inhibitor CKB, GuideToPharmacologyInteractions, ChemblInteractions 24362531, 26965451, 26285778
MET 4233 PF-04217903 CHEMBL2001019 inhibitor TALC, MyCancerGenome, ChemblInteractions
MET 4233 CHEMBL509101 CHEMBL509101 DrugBank 10592235
MET 4233 CHEMBL561660 CHEMBL561660 DrugBank 10592235
MET 4233 CABOZANTINIB CHEMBL2105717 antagonist, inhibitor DrugBank, TdgClinicalTrial, TALC, ClearityFoundationClinicalTrial, MyCancerGenomeClinicalTrial, CGI, GuideToPharmacologyInteractions, OncoKB, CancerCommons, MyCancerGenome, TTD, CIViC, CKB 21606412, 21926191, 27279544, 27462141, 27694386, 25971939, 28192597, 26432786, 28396313
MET 4233 PHA-665752 CHEMBL450786 inhibitor CKB, GuideToPharmacologyInteractions 24165158, 23542356, 21266357
MET 4233 AMG-208 CHEMBL496102 inhibitor TALC, MyCancerGenome, ChemblInteractions
MET 4233 Savolitinib CHEMBL3545336 inhibitor CKB, ChemblInteractions, CIViC 27694386, 25779944, 28644771, 28396313
MET 4233 PANITUMUMAB CHEMBL1201827 CKB, CGI 23729478
MET 4233 BEVACIZUMAB CHEMBL1201583 CKB 26965451, 26432108, 25363205
MET 4233 SELUMETINIB CHEMBL1614701 CKB 24939055
MET 4233 GANETESPIB CHEMBL2103879 CKB 26483207
MET 4233 ALVESPIMYCIN CHEMBL383824 CKB 26483207
MET 4233 FLUOROURACIL CHEMBL185 CKB 26432108
MET 4233 SORAFENIB CHEMBL1336 CKB 25363205
MET 4233 ARRY-300 CHEMBL3545359 inhibitor ChemblInteractions
MET 4233 FORETINIB CHEMBL1230609 inhibitor TALC, MyCancerGenome, TdgClinicalTrial, CKB, GuideToPharmacologyInteractions, ChemblInteractions, CIViC, CancerCommons, TTD 23213094, 26779812
MET 4233 CRIZOTINIB CHEMBL601719 inhibitor TdgClinicalTrial, CKB, DrugBank, GuideToPharmacologyInteractions, OncoKB, ChemblInteractions, MyCancerGenome, TALC, MyCancerGenomeClinicalTrial, ClearityFoundationBiomarkers, CGI, CIViC, DoCM 28522754, 28765324, 25971938, 27343442, 25971939, 27694386, 27595477, 27283993, 27149990, 25232318, 27393507, 26483207, 26432108, 17483355, 21266357, 26779812, 15494073, 28514312, 28396313, 10592235, 22594847, 26729443, 15735036, 16397241, 19096300, 26215952, 21623265, 22162573, 21716144, 27325282, 25922291, 23729478, 26547802, 1104268, 10417759, 25157968, 9826708, 11750879, 12460923
MET 4233 CLOFIBRATE CHEMBL565 inhibitor GuideToPharmacologyInteractions
MET 4233 PYRAZINAMIDE CHEMBL614 inhibitor CKB, GuideToPharmacologyInteractions 19783361, 15064724, 19723643
MET 4233 BMS-794833 CHEMBL3545119 inhibitor ChemblInteractions
MET 4233 ABT-700 CHEMBL3545419 inhibitor CKB, ChemblInteractions
MET 4233 BPI-9016 CHEMBL3545236 inhibitor ChemblInteractions
MET 4233 GEFITINIB CHEMBL939 CKB, CIViC 17463250, 24165158, 23542356, 27612490
MET 4233 PACLITAXEL CHEMBL428647 CKB 28514312, 26432108
MET 4233 OLAPARIB CHEMBL521686 CKB 26779812
MET 4233 CAPECITABINE CHEMBL1773 CKB 26432108
MET 4233 LEUCOVORIN CHEMBL1679 CKB 26432108
MET 4233 MK-2461 CHEMBL1822792 inhibitor TALC, MyCancerGenome, GuideToPharmacologyInteractions, ChemblInteractions
MET 4233 CHEMBL527066 CHEMBL527066 DrugBank 10592235
MET 4233 CHEMBL462712 CHEMBL462712 DrugBank 10592235
MET 4233 SGX-523 CHEMBL1236107 inhibitor TdgClinicalTrial, CKB, GuideToPharmacologyInteractions, ChemblInteractions, DrugBank, TTD 26483207, 19934279, 10592235
MET 4233 EMIBETUZUMAB CHEMBL3301578 antibody CKB, GuideToPharmacologyInteractions 27803065, 25231402
MET 4233 ONARTUZUMAB CHEMBL1743051 antagonist, inhibitor, antibody CIViC, GuideToPharmacologyInteractions, ChemblInteractions, TTD, TALC, MyCancerGenome, CancerCommons, TdgClinicalTrial, CKB 22389872, 23882082, 24101053, 27918764
MET 4233 ALECTINIB CHEMBL1738797 inhibitor GuideToPharmacologyInteractions
MET 4233 LY-2875358 CHEMBL2109517 antibody TALC, MyCancerGenome
MET 4233 JNJ-38877605 CHEMBL2133806 inhibitor TALC, CKB, ChemblInteractions 23729478
MET 4233 MK-8033 CHEMBL2323775 inhibitor ChemblInteractions, TTD
MET 4233 RILONACEPT CHEMBL1201830 stimulator TTD
MET 4233 CABOZANTINIB S-MALATE CHEMBL2103868 inhibitor ChemblInteractions
MET 4233 OSIMERTINIB CHEMBL3353410 CKB, CGI 27694386, 27393507, 27252416
MET 4233 LAPATINIB CHEMBL554 CKB, CGI 27595477, 26432108
MET 4233 CETUXIMAB CHEMBL1201577 CKB, CIViC 23729478
MET 4233 CARBOPLATIN CHEMBL1351 CKB 28514312
MET 4233 VELIPARIB CHEMBL506871 CKB 26779812
MET 4233 AFATINIB CHEMBL1173655 CKB 27694386
MET 4233 CHEMBL1081312 CHEMBL1081312 CKB 26483207
MET 4233 DACTOLISIB CHEMBL1879463 CKB 24939055
MET 4233 OXALIPLATIN CHEMBL414804 CKB 26432108
MET 4233 BMS-698769 CHEMBL3545299 inhibitor ChemblInteractions
MET 4233 BMS-777607 CHEMBL460702 inhibitor TALC, MyCancerGenome, CKB, GuideToPharmacologyInteractions, ChemblInteractions 20515943, 22286523, 28396313
MET 4233 K-252A CHEMBL281948 CKB, DrugBank 17139284, 17016423, 10592235, 12118367
MET 4233 CHEMBL503090 CHEMBL503090 DrugBank 10592235
MET 4233 AMOXICILLIN CHEMBL1082 inhibitor GuideToPharmacologyInteractions
MET 4233 AMG-337 CHEMBL3545212 inhibitor CKB, GuideToPharmacologyInteractions, ChemblInteractions 26432108, 27196782, 27196749, 25326232
MET 4233 CAPMATINIB CHEMBL3188267 inhibitor OncoKB, ChemblInteractions, GuideToPharmacologyInteractions, TALC, MyCancerGenome, CancerCommons, CIViC, CKB 21918175, 25971939, 25971938, 28765324, 27694386, 28783719, 15494073, 28396313
MET 4233 TANESPIMYCIN CHEMBL109480 inhibitor GuideToPharmacologyInteractions
MET 4233 TIVANTINIB CHEMBL2103882 inhibitor TALC, MyCancerGenome, TdgClinicalTrial, GuideToPharmacologyInteractions, ChemblInteractions, CancerCommons, MyCancerGenomeClinicalTrial, TTD
MET 4233 MGCD-265 CHEMBL254760 inhibitor TALC, MyCancerGenome, TdgClinicalTrial, CKB, ChemblInteractions, CancerCommons 28765324, 27694386, 15494073
MET 4233 EMD-1204831 CHEMBL3545053 inhibitor CKB, ChemblInteractions 25326232
MET 4233 MERESTINIB CHEMBL3545307 inhibitor CKB, ChemblInteractions 27694386, 23275061, 26757360
MET 4233 ERLOTINIB CHEMBL553 PharmGKB, CKB 24101053, 27803065, 27694386
MET 4233 BMS-817378 CHEMBL3545050 inhibitor ChemblInteractions
MET 4233 CRENOLANIB CHEMBL2105728 inhibitor MyCancerGenomeClinicalTrial
MET 4233 TRASTUZUMAB CHEMBL1201585 CKB, CGI 22850551, 26432108
MET 4233 IMATINIB CHEMBL941 CKB 28514312
MET 4233 RILOTUMUMAB CHEMBL1743063 CKB
MET 4233 RUCAPARIB CHEMBL1173055 CKB 26779812
MET 4233 DASATINIB CHEMBL1421 CKB 26483207
MET 4233 TRAMETINIB CHEMBL2103875 CKB 28783719
MET 4233 AMUVATINIB CHEMBL2103851 inhibitor MyCancerGenome, TALC, ChemblInteractions, DrugBank, TTD, TdgClinicalTrial, CKB 24326130
MET 4233 Tepotinib CHEMBL3402762 inhibitor MyCancerGenome, CKB, GuideToPharmacologyInteractions, ChemblInteractions 25256830, 23553846, 26358474
MET 4233 VEMURAFENIB CHEMBL1229517 CGI, CIViC 27325282, 26359985
MET 4233 FICLATUZUMAB CHEMBL1743018 CKB 24901237
MET 4233 PONATINIB CHEMBL1171837 CKB 25122427
MET 4233 SAR-125844 CHEMBL3545325 inhibitor CKB, ChemblInteractions 25504634
MET 4233 TAS-115 CHEMBL3545144 inhibitor CKB, ChemblInteractions 24140932
MET 4233 CHEMBL458997 CHEMBL458997 CKB 26090892
MET 4233 ROCILETINIB CHEMBL3545308 CKB, CGI 27283993, 27252416
MET 4233 GOLVATINIB CHEMBL3039525 inhibitor CKB, GuideToPharmacologyInteractions, ChemblInteractions 19832844
MET 4233 PILARALISIB (CHEMBL3218575) CHEMBL3218575 CKB 25637314

Variant-drug associations (data source: PharmGKB)
Gene Name Variant Alleles Chemical Phenotype Category Significance Notes Sentence Publications Annotation ID